# One week left to invest—and a look at what’s next | Sempresto

- Canonical URL: https://wefunder.com/feed/430239
- Entity ID: wefunder:feed_item:430239
- Published at: 2026-10-20 22:01:23 UTC
- Updated at: 2026-10-20 23:04:12 UTC

## Author
Elizabeth Reczek

## Subject
Sempresto

## Content
Our Wefunder round closes next week. As we approach that milestone, our team is focused on the work ahead—and grateful to the investors helping us move Sempresto forward.Our mission continues to drive us: developing a new kind of autoinjector that we hope will make rescue medications easier to carry and harder to leave behind. Here’s where we plan to focus next:📱 Developing the companion app. Continuing development of the Sempresto companion app, with its features and regulatory strategy still being defined.🔬 Advancing device development. Working toward completion of user testing and design lock, followed by manufacturing runs and stability testing with our production partner.📋 Preparing our FDA submission. Preparing a submission under the 505(b)(2) pathway. Of course, our projected development timelines remain estimates, and approval depends on FDA review and is not guaranteed.There is meaningful work ahead, and we’re excited to take it on. Thank you to everyone who has chosen to be part of Sempresto’s story.If you’re considering investing or adding to your investment, there’s one week left in this round. Review the offering details and risk factors at wefunder.com/sempresto.Sempresto’s autoinjector is investigational. It has not been approved by FDA and is not available for sale.With gratitude,LizElizabeth Reczek, PhDCo-Founder & CEO, Sempresto